Higher Concentrations of Alanine Aminotransferase within the Reference Interval Predict Nonalcoholic Fatty Liver Disease
Open Access
- 1 April 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 53 (4), 686-692
- https://doi.org/10.1373/clinchem.2006.081257
Abstract
Background: In nonalcoholic fatty liver disease (NAFLD), increased alanine aminotransferase (ALT) concentrations are considered to be a consequence of hepatocyte damage. We performed a prospective study to examine the association between ALT within its reference interval and risk for subsequent development of NAFLD. Methods: The study cohort comprised 5237 healthy men without diagnosed NAFLD and without increases of either ALT (≥35 U/L) or γ-glutamyltransferase (GGT; ≥40 U/L) above the reference intervals. We assessed alcohol intake via self-reporting (questionnaire) and performed biochemical tests for liver and metabolic function and abdominal ultrasonography. We used the Cox proportional hazards model to calculate the adjusted hazard ratios (aHRs) in the model for NAFLD. Results: During 13 276.6 person-years of follow-up over a 4-year period, 984 new incident cases of NAFLD developed. We adjusted for age, weight change, body mass index, glucose, blood pressure, triglycerides, HDL cholesterol, smoking, alcohol consumption, regular exercise, homeostasis model assessment of insulin resistance, C-reactive protein, and incident diabetes. Compared with an ALT concentration of <16 U/L, aHR values (95% confidence intervals) for ALT concentrations were 1.53 (1.18–1.98), 1.66 (1.29–2.13), 1.62 (1.26–2.08), and 2.21 (1.73–2.81) for ALT concentrations of 16–18, 19–21, 22–25, and 26–34 U/L, respectively. This relationship remained significant even among normal-weight participants who were still within the reference interval of ALT and GGT at all follow-up examinations. Conclusions: In apparently healthy, nondiabetic Korean men, increased ALT concentration, even within the reference interval, was an independent predictor of incident NAFLD.Keywords
This publication has 30 references indexed in Scilit:
- Alanine aminotransferase as a marker of non‐alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular diseaseDiabetes/Metabolism Research and Reviews, 2006
- Hepatic Enzymes, the Metabolic Syndrome, and the Risk of Type 2 Diabetes in Older MenDiabetes Care, 2005
- The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver DiseaseAnnals of Internal Medicine, 2005
- Elevated Alanine Aminotransferase Predicts New-Onset Type 2 Diabetes Independently of Classical Risk Factors, Metabolic Syndrome, and C-Reactive Protein in the West of Scotland Coronary Prevention StudyDiabetes, 2004
- Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort studyBMJ, 2004
- Nonalcoholic Fatty Liver DiseaseThe New England Journal of Medicine, 2002
- Nonalcoholic Fatty Liver DiseaseDiabetes, 2001
- Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients.Diabetes, 2000
- Association of nonalcoholic fatty liver disease with insulin resistanceThe American Journal of Medicine, 1999
- Prospective Evaluation of Unexplained Chronic Liver Transaminase Abnormalities in Asymptomatic and Symptomatic PatientsThe American Journal of Gastroenterology, 1999